Cargando…

Risk factors of mortality in severe cutaneous adverse reactions patients with pulmonary involvement

Detalles Bibliográficos
Autores principales:	Hu, H, Kao, K, Huang, C, Yang, C, Hung, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363537/ http://dx.doi.org/10.1186/cc10726

Ejemplares similares

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Analysis of B cell subsets in severe cutaneous adverse reaction
por: Azukizawa, Hiroaki, et al.
Publicado: (2014)

Effects of immunomodulating therapies on mortality in patients with severe cutaneous adverse reactions in comparison with supportive care only: a systematic review
por: Zimmermann, Stefanie, et al.
Publicado: (2014)

Patch testing in drug cutaneous adverse reactions: value of the extemporaneous preparations
por: Assier, Haudrey, et al.
Publicado: (2014)

A severe cutaneous reaction caused by acetaminophen in a pediatric patient
por: Schroeder, Jan, et al.
Publicado: (2014)

HLA-B*58:01 allele is strongly associated with allopurinol-induced severe cutaneous adverse reactions in a Thai population
por: Jantararoungtong, Thawinee, et al.
Publicado: (2014)

An immunohistochemical study of the granulysin expression of 6 types of proven adverse cutaneous drug reaction
por: Weinborn, Marie, et al.
Publicado: (2014)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Involvement of the activating receptor NKG2D in cutaneous hypersensitivity drug reactions
por: Bellón, Teresa, et al.
Publicado: (2014)

Cutaneous drug-reactions to nevirapine: study of risk factors in 268 HIV-infected patients
por: Badaoui, L, et al.
Publicado: (2014)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Drugs inducing T-cell mediated cutaneous adverse reactions and contact sensitizers evoke similar responses in THP-1 cells
por: Gonçalo, Margarida, et al.
Publicado: (2014)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
por: Yonekura, Kentro, et al.
Publicado: (2015)

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

Computed tomographic pulmonary angiographic findings to predict adverse outcomes in acute pulmonary embolism
por: Tajarernmuang, P, et al.
Publicado: (2015)

Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions
por: Zitha, Eddy, et al.
Publicado: (2014)

Differential cytokine/chemokine profiles and reactivation of human herpes viruses in various forms of cutaneous adverse drug reactions. A comparative study in Taiwan
por: Chu, Chia-Yu, et al.
Publicado: (2014)

Independent risk factors for long-term mortality in patients with severe infection
por: Francisco, J, et al.
Publicado: (2015)

Adverse reactions to food in patients with mastocytosis
por: Pucino, Valentina, et al.
Publicado: (2011)

Factors related to the mortality of patients with severe sepsis and septic shock
por: Machado, RL, et al.
Publicado: (2009)

Intensive care infections: risk factors and mortality
por: Silvestri, S, et al.
Publicado: (2008)

Basophil activation test is food adverse reactions
por: Pignatti, Patrizia, et al.
Publicado: (2011)

Epidermiology of adverse drug reactions (ADRs) in the elderly
por: Ju-Young, Kim, et al.
Publicado: (2014)

Non hepatitis jaundice - adverse reaction to rifampicin
por: Laza, Ruxandra, et al.
Publicado: (2014)

Causes and risk factors of maternal mortality in the ICU
por: Kaddour, C, et al.
Publicado: (2008)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Prognostic factors for very short-term mortality in severe sepsis
por: Silva, E, et al.
Publicado: (2010)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis
por: Balak, Deepak MW, et al.
Publicado: (2011)

Severe protein C deficiency association with organ dysfunction and mortality in patients with severe sepsis
por: Vail, M, et al.
Publicado: (2007)

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
por: Chen, Chun-Bing, et al.
Publicado: (2018)

Outcome and mortality risk factors of patients presenting to the ICU with severe sepsis and septic shock
por: Bhurayanontachai, R, et al.
Publicado: (2008)

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014)

Factors associated with mortality in severe burn patients
por: Peñuelas, O, et al.
Publicado: (2006)

What are the psychological correlates of perceived adverse food reactions?
por: Mahmood, Saliha
Publicado: (2011)

Effects of cardiac output levels on the measurement of transpulmonary thermodilution cardiac output in patients with acute lung injury
por: Kao, K, et al.
Publicado: (2012)

Saddle embolism is associated with the major adverse events in patients with nonhigh-risk pulmonary embolism
por: Kim, H, et al.
Publicado: (2012)

Septic shock and the use of norepinephrine in a high dependency unit - mortality and adverse events
por: Hallengren, M, et al.
Publicado: (2015)

P04.25. Complementary medicine use and potential adverse reactions amongst HIV-positive people
por: Braun, L, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i2ivnc3gsmtvb74f4vj5601upg